Symbol
RNAC on Nasdaq
Investment type
Equity / Common Stock, $0.0001 par value per share
Latest Disclosed Ownership
9.56M shares
Security Ownership
36.9%

Timothy A. Springer ownership in Cartesian Therapeutics, Inc. Common Stock, $0.0001 par value per share (RNAC)

2025-01-15 - Timothy A. Springer has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 9.56M shares of Cartesian Therapeutics, Inc. Common Stock, $0.0001 par value per share (RNAC). This represents 36.9% percent ownership of the company. In their previous filing dated 2024-12-23, SPRINGER TIMOTHY A had reported owning 9.53M shares, indicating an increase of 0.22% percent.